TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot

The U.S. Food and Drug Administration approved Weltruza as an extended-release injectable suspension for adults with schizophrenia.
Read the full report on Asianet Newsable
Story file
- Section
- India
- First reported by
- Asianet Newsable
- Reporter
- stocktwits inc
- Published
- Saturday, 10 October 2026, 12:20 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.





